The global amino acid metabolism drug market is estimated to grow at a significant CAGR during the forecast period. The rising prevalence of amino acid metabolism disorders such as Argininosuccinic academia, Citrullinemia, Homocystinuria, Phenylketonuria, and Maple syrup urine disease will drive the growth of the global amino acid metabolism drug market. According to the National Centre for Biotechnology Information, the global prevalence of phenylketonuria is 6.002 per 100,000 neonates in 2020. It is the disease caused due to congenital defects in the phenylalanine metabolism, an amino acid, which further leads to irreversible nerve ending.

Free Sample Copy @ https://www.omrglobal.com/request-sample/amino-acid-metabolism-drug-market

Additionally, the rising demand for amino acids from the food, pharmaceuticals, and nutraceuticals industry will also propel the growth of the market. The amino acids such as glutamic acids are prescribed as food supplements to maintain the amino acid balance in the infants.. The major restraining factors for the growth of the market include lack of awareness about amino acid metabolic disorders and higher cost of amino acid supplements.

A Full Report of Global Amino Acid Metabolism Drug Market is Available at:
https://www.omrglobal.com/industry-reports/amino-acid-metabolism-drug-market

Amino acids are the building blocks of the body consists of hydrogen (H), nitrogen (N), oxygen (O), and carbon (C), and others, which further join together to form proteins. There are more than 500 amino acids naturally available, among which only 20 are found in the genetic code of an individual. The disorders in which the body fails to metabolize the amino acids or the problem associated with the uptake of the amino acids is termed as amino acid metabolism disorder. The following conditions are inherited generally and could be lethal if not diagnosed or treated early. There are many amino acid metabolism drugs under the pipeline including SYNB1618 (Synlogic Inc.), CNSA-001 (Censa Pharmaceuticals), HMI-102 (Homology Medicines), BMN 307 (Biomarin Pharmaceuticals), and many more.

The key players contributing to the growth of the global amino acid metabolism drug market by adopting various strategies such as product launches and developments, mergers and acquisitions, partnerships, and agreements, include Merck KGaA, Novartis AG, Takeda Pharmaceutical Company Ltd., AstraZeneca Plc., Boehringer Ingelheim, KOWA, Kythera, Fuji yakhni, LG Life Science, Mitsubishi Tanabe Pharma. For instance, SYNB1618, by Synlogic, was under the phase 1-2a clinical trial in September 2019. The drug is a novel therapy for the treatment of all patients of Phenylketonuria.

Global Amino Acid Metabolism Drug Market – Segmentation
By Drug Type
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Saproterin Dihydrochloride
Others
By Indication
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
By Distribution Channel
Hospital
Retail Pharmacy
Online
Others

Global Amino Acid Metabolism Drug Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Merck KGaA
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Mitsubishi Tanabe Pharma

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/amino-acid-metabolism-drug-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404